FDA approves Neuralstem's stem cell trial

09/21/2009 | Chicago Tribune (tiered subscription model)

Neuralstem has received FDA approval to test the safety of injecting neural stem cells into the spinal cords of patients with amyotrophic lateral sclerosis, or Lou Gehrig's disease. Dr. Eva Feldman, a University of Michigan neurologist, will serve as the principal investigator of the clinical trial, which will be conducted at Emory University in Atlanta.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA